Latest news with #MikeMcCartney
Yahoo
03-07-2025
- Entertainment
- Yahoo
AI, TikTok and playing cupid...Pete shares a couple of thoughts
This week there are a couple of things I want to write about. The first is AI. Not so long ago Trump was in the Gulf States on an official visit, and to all intents and purposes was very fruitful for America, with many deals being done. After the visit, AI videos of the leaders of the Gulf States started to appear. They were slagging Trump off, but it was AI. To a lot of the general public, these could have appeared totally legitimate, such is the quality. Surely this is very dangerous. There should be more responsible labelling to show the authenticity of content online to avoid confusion and misinformation. Talking of Trump, I hate the way he calls the mainstream media 'another fake news channel or paper' when they don't agree with him. READ MORE: After a busy week, Pete asks himself if it's time to put his feet up I've recently had a video taken down from TikTok, saying it had been removed for 'violating community guidelines'. I've got to tell you about this clip. It was from one of my podcasts. I did a fabulous interview with Mike McCartney (known professionally as Mike McGear). We promoted a short clip from the podcast. I'd asked: 'Your name. McGear, how did you get it?' Mike responded: 'We were looking around ordinary words used in Liverpool, and we came up with gear, which can be clothes or a term of endearment, and that's how we got the name 'Mc', initials of Mike McCartney, plus Gear. When TikTok took it down, we think the moderating tools had picked up on the word 'gear' which has on occasion been used as a slang word for drugs. After challenging it, it was eventually put back up. I got a message this week that made me so happy. 'Hi Peter, just wanted to thank you for my life. 'My mum and dad met on your radio show in the 90s on your date segment, and they subsequently had three kids. 'I wouldn't be here if it wasn't for you.' This little note made my job worthwhile, and in fact, we celebrated ten weddings through my evening encounters slot, plus many more found love. Two years ago, when the Pride march was on, a young lady came up and hugged me, and informed me that her mum and dad had also met because of me. The Cilla Black bronze statue in Mathew Street was created by Emma Rodgers and is now one of the big tourist attractions in Liverpool. Some people don't realise that all over her dress are pictures of her life. There is one of me, just above her bottom. After years of people put their arms around the statue to have their photograph taken, many images engraved have now been worn down. Thank goodness, I am still there! READ MORE: Coping with grief and loss is a personal journey, and there is no right or wrong way to grieve READ MORE: As Leanne Campbell leaves the airwaves, I reflect on the changing landscape of local radio
New York Times
10-03-2025
- Business
- New York Times
X users experience multiple outages: How did it impact NFL free agency news cycle?
Users of the social media platform X, formerly known as Twitter, experienced intermittent outages Monday morning, according to Downdetector, which tracks user reports on problems across various websites. Three major outages were reported between 6 a.m. and noon Eastern time, with a peak of nearly 41,000 reports of outages at 10 a.m. Most reported problems were associated with the X app. Advertisement X is commonly used as a news-breaking platform, and Monday's outages coincided with the beginning of the NFL's free agency negotiation period — one of the busiest days on the NFL calendar in terms of player movement and roster acquisition. Within the first hour of the negotiation period, 17 of The Athletic's Top 150 free agents were reported to have agreed to new contract terms. The break in routine didn't slow the news cycle, and many users were pushed elsewhere to stay up to date. Per Google Trends, three of the top five related queries for searches of 'twitter down' mentioned NFL free agency and the No. 2 related search was 'Bluesky,' a competing social media site. When X began working again in the early afternoon, Mike McCartney, an NFL agent with Vayner Sports, posted 'Not enjoying this game of yo-yo @X.' Elon Musk, who purchased X in 2022, acknowledged the outage on Monday afternoon in a post that read, 'There was (still is) a massive cyberattack against X. We get attacked every day, but this was done with a lot of resources. Either a large coordinated group and/or a country is involved. Tracing …'.
Yahoo
28-01-2025
- Business
- Yahoo
Schrödinger Selects Sapio Sciences to Enhance In Silico Drug Discovery from Plasmid to Structure
Configurable informatics platform improves lab efficiency, data tracking, and resource management from plasmid to structure BALTIMORE, January 28, 2025--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced that Schrödinger, a global leader in computational chemistry, has adopted the Sapio Platform to improve data management, enhance lab efficiency, and accelerate the discovery of novel molecules. By deploying Sapio's unified informatics platform, including Sapio LIMS and Sapio ELN, Schrödinger is transforming its recently acquired wet lab operations, integrating data, and streamlining workflows. Schrödinger established its internal wet lab after acquiring a contract research organization (CRO) in 2021. However, the lab's reliance on manual, paper-based processes posed significant challenges in scalability, traceability, and operational efficiency. Transitioning to Sapio's no-code informatics platform has provided a scalable, flexible solution that simplifies operations and accelerates scientific progress. Dr. Rajesh Kumar, Senior Director of Drug Discovery at Schrödinger, commented: "Sapio's solution has allowed us to digitize critical lab functions, improve efficiency, and ensure seamless sample traceability across our research and discovery processes. By unifying data and automating workflows, we're able to focus on advancing our research with greater speed and confidence." Since adopting the Sapio Platform, Schrödinger has realized several key benefits, including: Improved visibility across the discovery process: Researchers now have a clear, real-time view of every stage, optimizing resource use and improving overall efficiency. Comprehensive data traceability: Detailed documentation of lab activities simplifies audits, accelerates regulatory filings, and ensures full compliance. Optimized resource allocation: Access to historical data enables better planning, budgeting, and distribution of resources across multiple projects. Long-term knowledge retention: A centralized knowledge base allows scientists to easily retrieve critical data, supporting ongoing and future research initiatives. Mike McCartney, Chief Commercial Officer at Sapio Sciences, commented: "Schrödinger's adoption of the Sapio Platform highlights the increasing demand for configurable informatics solutions that unify complex lab environments. By eliminating data silos and improving lab efficiency, we're enabling Schrödinger to accelerate drug discovery and drive innovation." The full story on the Schrödinger implementation can be found here. About Schrödinger Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger's software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs and is advancing three clinical-stage oncology programs. Founded in 1990, Schrödinger has approximately 900 employees operating from 15 locations globally. To learn more, visit About Sapio Sciences At Sapio Sciences, our mission is to improve lives by accelerating discovery and diagnostics. Our cloud-based solutions—LIMS, ELN, and Scientific Data Management—are unified on a flexible, configurable, and AI-powered informatics platform, streamlining complex workflows, unifying scientific data, and enabling faster, smarter decisions across biopharma research and development, clinical diagnostics, and manufacturing. Trusted by global leaders and innovators worldwide, we support a wide range of best-in-class applications, from NGS genomic sequencing and bioanalysis to bioprocessing, stability studies, histopathology, antibody discovery, and in vivo studies. Discover how Sapio Sciences can revolutionize your lab operations at and follow us on LinkedIn. View source version on Contacts For further information, please contact: Zyme Communications Anna BakewellTel: +44 (0)7801 098 242Email: Tim BrookHead of PR, Sapio SciencesTel: +44 (0)7760 766 213Email: press@
